Autori: Messinger D
| Naslov | FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study (Article) |
| Autori | Brodowicz Thomas Ciuleanu Tudor E Radosavljevic Davorin Z Shacham-Shmueli Einat Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Dank M Purkalne Gunta Messinger D Zielinski Christoph |
| Info | ANNALS OF ONCOLOGY, (2013), vol. 24 br. 7, str. 1769-1777 |
| Projekat | CECOG |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
     |
| Naslov | Fib-4 Score Is a Stronger Predictor of Virological Response Than Liver Biopsy (Metavir) in Hepatitis C Genotype 1 Patients: Interim Data From the Prophesys Trial (Meeting Abstract) |
| Autori | Ferenci Peter Marcellin Patrick Puoti M Orlandini A Bozic M Schuller J Mulkay JP Tice A Pruthi J Craxi A Messinger D Tatsch F Horban A |
| Info | JOURNAL OF HEPATOLOGY, (2011), vol. 54 br. , Suppl. 1, str. S170-S170 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
